Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 5 Neoplasms 4 Recurrence 3 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Basal Cell 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Head and Neck Neoplasms 2 Cutaneous Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrent Squamous Cell Carcinoma of Head 1 Ovarian Neoplasms 1 Natural Killer/T-cell Lymphoma 1 Multiple Myeloma 1 Malignant Solid Tumor 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Kidney Neoplasms 1 Hemangiosarcoma 1 Glioma 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Rituximab 47 Cyclophosphamide 26 fludarabine 13 ibrutinib 12 Doxorubicin 11 Vincristine 10 Etoposide 10 Cytarabine 10 Prednisone 9 Bortezomib 9 pembrolizumab 7 fludarabine phosphate 6 Lenalidomide 6 Inotuzumab Ozogamicin 6 obinutuzumab 5 Mycophenolic Acid 5 Melphalan 5 Carmustine 5 tositumomab I-131 4 ibritumomab tiuxetan 4 Tacrolimus 4 Prednisolone 4 Methotrexate 4 Gemcitabine 4 Bendamustine Hydrochloride 4 Antilymphocyte Serum 4 tocilizumab 3 tazemetostat 3 Whole-Body Irradiation 3 Vorinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, B-Cell × cemiplimab × Clear all

NCT02651662 2026-06-02

CLIO-1

Regeneron Pharmaceuticals

Phase 1 Completed

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡